Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) Invested Capital (2016 - 2025)

Historic Invested Capital for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $141.2 million.

  • Ultralife's Invested Capital rose 335.58% to $141.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.2 million, marking a year-over-year increase of 335.58%. This contributed to the annual value of $136.9 million for FY2024, which is 746.31% up from last year.
  • Latest data reveals that Ultralife reported Invested Capital of $141.2 million as of Q3 2025, which was up 335.58% from $142.1 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Invested Capital registered a high of $142.1 million during Q2 2025, and its lowest value of $118.4 million during Q1 2023.
  • Its 4-year average for Invested Capital is $129.4 million, with a median of $129.2 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 296.86% in 2021, then skyrocketed by 1123.48% in 2024.
  • Ultralife's Invested Capital (Quarter) stood at $118.8 million in 2021, then rose by 7.26% to $127.4 million in 2023, then rose by 7.46% to $136.9 million in 2024, then increased by 3.12% to $141.2 million in 2025.
  • Its last three reported values are $141.2 million in Q3 2025, $142.1 million for Q2 2025, and $139.7 million during Q1 2025.